VC-backed Gamida Cell hires chief medical officer
Jerusalem-based Gamida Cell, a provider of cellular and immune therapies that treat cancer and orphan genetic diseases, has appointed Dr. Ronit Simantov as its new chief medical officer. Previously, Simantov was vice president and head of global medical affairs at Pfizer Oncology. Gamida's backers include Novartis, Clal Biotechnology Industries, Elbit Imaging, Israel Healthcare Ventures, Shavit Capital Fund, VMS Investment Group, Denali Ventures, Auriga Ventures and Israel Biotech Fund.
10 July 2017•4 mins read
